View in EDS

Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?

Saved in:
Bibliographic Details
Title: Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
Authors: Jehanno N; Department of Nuclear Medicine, Curie Institute, Paris, France. nina.jehanno@curie.fr., Corradini N; Department of Pediatric Oncology, Institute for Paediatric Haematology and Oncology, Léon Bérard Center, Lyon, France., Gaspar N; Department of Oncology for Child and Adolescent, Gustave Roussy Cancer Campus, Villejuif, France., Brahmi M; Department of Medical Oncology, Léon Bérard Center, Lyon, France., Valentin T; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Revon Rivière G; Department of Pediatric Hematology, Immunology and Oncology, APHM - La Timone Children's Hospital, Marseille, France., Lervat C; Department of Pediatric and AYA Oncology, Centre Oscar Lambret, Lille, France., Probert J; Department of Pediatric Onco-hematology, University Hospital of Rennes, Rennes, France., Entz-Werle N; Department of Pediatric Oncology, CHU, Strasbourg, France., Mansuy L; Children's University Hospital, Department of Pediatric Hematology and Oncology, Nancy, France., Plantaz D; Department of Pediatric Hematology and Oncology, University Hospital of Grenoble, Grenoble, France., Rios M; Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre-lès-Nancy, France., Saumet L; Department of Pediatric Onco-Hematology, University Hospital of Montpellier, Montpellier, France., Verité C; Department of Pediatric and Adolescent Hematology and Oncology, Pellegrin Hospital, Bordeaux, France., Castex MP; Pediatric Oncology Immunology Hematology Unit, Children's University Hospital - Toulouse University Hospital, Toulouse, France., Thebaud E; Department of Pediatric Oncology, Hôpital Mère-Enfant, Nantes, France., Cassou-Mounat T; Nuclear Medicine Department, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Plissonnier AS; DREH Pôle Promotion, Institut Curie, Saint-Cloud, France., Mosseri V; Department of Biostatistics, Curie Institut, Saint-Cloud, France., Cordero C; Adolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France., Laurence V; Adolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France.
Source: British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1605-1612. Date of Electronic Publication: 2024 Oct 08.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39379569
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Role of <superscript>18</superscript>F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jehanno+N%22">Jehanno N</searchLink>; Department of Nuclear Medicine, Curie Institute, Paris, France. nina.jehanno@curie.fr.<br /><searchLink fieldCode="AU" term="%22Corradini+N%22">Corradini N</searchLink>; Department of Pediatric Oncology, Institute for Paediatric Haematology and Oncology, Léon Bérard Center, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Gaspar+N%22">Gaspar N</searchLink>; Department of Oncology for Child and Adolescent, Gustave Roussy Cancer Campus, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Brahmi+M%22">Brahmi M</searchLink>; Department of Medical Oncology, Léon Bérard Center, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Valentin+T%22">Valentin T</searchLink>; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Revon+Rivière+G%22">Revon Rivière G</searchLink>; Department of Pediatric Hematology, Immunology and Oncology, APHM - La Timone Children's Hospital, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Lervat+C%22">Lervat C</searchLink>; Department of Pediatric and AYA Oncology, Centre Oscar Lambret, Lille, France.<br /><searchLink fieldCode="AU" term="%22Probert+J%22">Probert J</searchLink>; Department of Pediatric Onco-hematology, University Hospital of Rennes, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Entz-Werle+N%22">Entz-Werle N</searchLink>; Department of Pediatric Oncology, CHU, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Mansuy+L%22">Mansuy L</searchLink>; Children's University Hospital, Department of Pediatric Hematology and Oncology, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Plantaz+D%22">Plantaz D</searchLink>; Department of Pediatric Hematology and Oncology, University Hospital of Grenoble, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Rios+M%22">Rios M</searchLink>; Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre-lès-Nancy, France.<br /><searchLink fieldCode="AU" term="%22Saumet+L%22">Saumet L</searchLink>; Department of Pediatric Onco-Hematology, University Hospital of Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Verité+C%22">Verité C</searchLink>; Department of Pediatric and Adolescent Hematology and Oncology, Pellegrin Hospital, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Castex+MP%22">Castex MP</searchLink>; Pediatric Oncology Immunology Hematology Unit, Children's University Hospital - Toulouse University Hospital, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Thebaud+E%22">Thebaud E</searchLink>; Department of Pediatric Oncology, Hôpital Mère-Enfant, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Cassou-Mounat+T%22">Cassou-Mounat T</searchLink>; Nuclear Medicine Department, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Plissonnier+AS%22">Plissonnier AS</searchLink>; DREH Pôle Promotion, Institut Curie, Saint-Cloud, France.<br /><searchLink fieldCode="AU" term="%22Mosseri+V%22">Mosseri V</searchLink>; Department of Biostatistics, Curie Institut, Saint-Cloud, France.<br /><searchLink fieldCode="AU" term="%22Cordero+C%22">Cordero C</searchLink>; Adolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France.<br /><searchLink fieldCode="AU" term="%22Laurence+V%22">Laurence V</searchLink>; Adolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1605-1612. <i>Date of Electronic Publication: </i>2024 Oct 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39379569
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-024-02864-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1605
    Titles:
      – TitleFull: Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jehanno N
      – PersonEntity:
          Name:
            NameFull: Corradini N
      – PersonEntity:
          Name:
            NameFull: Gaspar N
      – PersonEntity:
          Name:
            NameFull: Brahmi M
      – PersonEntity:
          Name:
            NameFull: Valentin T
      – PersonEntity:
          Name:
            NameFull: Revon Rivière G
      – PersonEntity:
          Name:
            NameFull: Lervat C
      – PersonEntity:
          Name:
            NameFull: Probert J
      – PersonEntity:
          Name:
            NameFull: Entz-Werle N
      – PersonEntity:
          Name:
            NameFull: Mansuy L
      – PersonEntity:
          Name:
            NameFull: Plantaz D
      – PersonEntity:
          Name:
            NameFull: Rios M
      – PersonEntity:
          Name:
            NameFull: Saumet L
      – PersonEntity:
          Name:
            NameFull: Verité C
      – PersonEntity:
          Name:
            NameFull: Castex MP
      – PersonEntity:
          Name:
            NameFull: Thebaud E
      – PersonEntity:
          Name:
            NameFull: Cassou-Mounat T
      – PersonEntity:
          Name:
            NameFull: Plissonnier AS
      – PersonEntity:
          Name:
            NameFull: Mosseri V
      – PersonEntity:
          Name:
            NameFull: Cordero C
      – PersonEntity:
          Name:
            NameFull: Laurence V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 131
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1